Greatmark Investment Partners, Inc. Teva Pharmaceutical Industries LTD Transaction History

Greatmark Investment Partners, Inc.

$734 Million
Q4 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 02, 2021	SELL	$8.38 - $10.18 $164,256 - $199,538	-19,601 Closed	0 $0
Q2 2021 Aug 23, 2021	SELL	$9.9 - $11.56 $1.55 Million - $1.8 Million	-156,140 Reduced 88.85%	19,601 $194,000
Q1 2021 May 04, 2021	BUY	$10.34 - $12.81 $1.06 Million - $1.31 Million	102,205 Added 138.99%	175,741 $2.03 Million
Q4 2020 Feb 08, 2021	SELL	$8.61 - $11.04 $242,888 - $311,438	-28,210 Reduced 27.73%	73,536 $710,000
Q3 2020 Oct 28, 2020	SELL	$8.57 - $12.69 $194,778 - $288,418	-22,728 Reduced 18.26%	101,746 $917,000
Q2 2020 Aug 04, 2020	SELL	$8.12 - $13.12 $13,479 - $21,779	-1,660 Reduced 1.32%	124,474 $1.54 Million
Q1 2020 Apr 29, 2020	SELL	$6.69 - $13.45 $2,676 - $5,380	-400 Reduced 0.32%	126,134 $1.13 Million
Q4 2019 Jan 31, 2020	SELL	$6.53 - $10.72 $28,496 - $46,782	-4,364 Reduced 3.33%	126,534 $1.24 Million
Q3 2019 Oct 30, 2019	SELL	$6.16 - $9.6 $69,546 - $108,384	-11,290 Reduced 7.94%	130,898 $901,000
Q2 2019 Aug 05, 2019	BUY	$8.12 - $15.72 $143,951 - $278,684	17,728 Added 14.24%	142,188 $1.31 Million
Q1 2019 May 07, 2019	SELL	$15.58 - $20.01 $85,300 - $109,554	-5,475 Reduced 4.21%	124,460 $1.95 Million
Q4 2018 Feb 01, 2019	SELL	$14.59 - $23.84 $1.72 Million - $2.81 Million	-118,025 Reduced 47.6%	129,935 $2 Million
Q3 2018 Oct 31, 2018	BUY	$21.06 - $25.65 $33,169 - $40,398	1,575 Added 0.64%	247,960 $5.34 Million
Q2 2018 Aug 03, 2018	SELL	$16.77 - $24.71 $110,614 - $162,987	-6,596 Reduced 2.61%	246,385 $5.99 Million
Q1 2018 May 04, 2018	SELL	$16.68 - $22.07 $160,027 - $211,739	-9,594 Reduced 3.65%	252,981 $4.32 Million
Q4 2017 Feb 01, 2018	SELL	$11.23 - $19.1 $693,553 - $1.18 Million	-61,759 Reduced 19.04%	262,575 $4.98 Million
Q3 2017 Nov 02, 2017	BUY	$15.41 - $32.17 $5 Million - $10.4 Million	324,334	324,334 $5.71 Million

Others Institutions Holding TEVA

# of Institutions

671

Shares Held

571M

Call Options Held

21.1M

Put Options Held

9.94M

Black Rock Inc. New York, NY

43M
Shares

$699 Million
0.02% of portfolio
Clal Insurance Enterprises Holdings LTD Tel Aviv, L3

39M
Shares

$633 Million
7.75% of portfolio
Ion Asset Management Ltd. George Town, Grand Cayman, E9

36.7M
Shares

$596 Million
48.01% of portfolio
Menora Mivtachim Holdings Ltd.

28.4M
Shares

$461 Million
3.94% of portfolio
Exor Capital LLP London, X0

27.2M
Shares

$442 Million
17.5% of portfolio

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $18B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Greatmark Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Greatmark Investment Partners, Inc. with notifications on news.

Account